Home
Arch Venture Partners XII, 10% Owner: Neumora Therapeutics NMRA Buy · Filed 23/11/13
Trade details
- Type
- Insider buy
- Amount
- $745,189.06
- Shares · price
- 69,127 sh · $10.78 a share
- Held after
- 4,024,719 sh
- Trade date
- 23/11/08
- Filed
- 23/11/13
- Days to filing
- 5 days
7 insiders bought this week
- Insiders buying this week
- 7 insiders
- Holding change
- +1.7%
Neumora Therapeutics trades, last 26 weeks
What else happened in Neumora Therapeutics around then
Filed or reported within 30 days of the trade day · 23/10/09~23/12/08Arch Venture Partners XII's recent trades
- Arch Venture Partners XII
BuySeaport Therapeutics
BuySeaport Therapeutics
SPTX
$19.8M
1,100,000 sh
$19.8M
Filed 05/04
Traded 05/04
- Arch Venture Partners XII
BuyNeumora Therapeutics
BuyNeumora Therapeutics
NMRA
$5M
1,915,700 sh
$5M
Filed 25/10/29
Traded 25/10/27
- Arch Venture Partners XII
BuyPrime Medicine
BuyPrime Medicine
PRME
$10M
3,030,300 sh
$10M
Filed 25/08/01
Traded 25/08/01
- Arch Venture Partners XII
BuyMetsera
BuyMetsera
MTSR
$25.8M
1,432,224 sh
$25.8M
Filed 25/02/03
Traded 25/02/03
- Arch Venture Partners XII
BuyMetsera
BuyMetsera
MTSR
$14.2M
789,998 sh
$14.2M
Filed 25/02/03
Traded 25/02/03